Markets:

Overview

News

Currencies

International

Treasuries

Kodiak Sciences Inc - Common Stock (NQ:KOD)

35.51 -1.20 (-3.27%)

Streaming Delayed Price Updated: 10:57 AM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kodiak Sciences Inc - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 14, 2022

Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.

Via Benzinga

Kodiak Sciences: Q2 Earnings Insights ↗

August 09, 2022

Kodiak Sciences (NASDAQ:KOD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Via Benzinga

Analyst Ratings for Kodiak Sciences ↗

August 02, 2022

Analysts have provided the following ratings for Kodiak Sciences (NASDAQ:KOD) within the last quarter:

Via Benzinga

What 5 Analyst Ratings Have To Say About Kodiak Sciences ↗

May 11, 2022

Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings:

Via Benzinga

Recap of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 08, 2022

Via Benzinga

Kodiak's Eye Disease Candidate At Par With Regeneron's Eylea In Visual Acuity Gains ↗

August 08, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 08, 2022

Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday!

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗

August 02, 2022

Upgrades

Via Benzinga

Analyst Ratings for Kodiak Sciences ↗

April 12, 2022

Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings:

Via Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

June 07, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma...

Via Benzinga

Recap: Kodiak Sciences Q4 Earnings ↗

March 01, 2022

Kodiak Sciences (NASDAQ:KOD) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Kodiak...

Via Benzinga

79 Biggest Movers From Yesterday ↗

June 08, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...

Via Benzinga

United Airlines And 3 Other Stocks Insiders Are Buying ↗

June 07, 2022

Although US stocks closed slightly higher on Monday, there were a few notable insider trades.

Via Benzinga

Carnival And 3 Other Stocks Insiders Are Buying ↗

May 31, 2022

Although the Dow Jones jumped around 575 points on Friday, there were a few notable insider trades.

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

May 19, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...

Via Benzinga

The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate ↗

May 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

24 Stocks Moving in Thursday's Pre-Market Session ↗

May 19, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares rose 20.9% to $0.70 in pre-market trading after dropping 12% on Wednesday. Acorda Therapeutics recently posted a Q1 loss of $1.66 per share.

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

Bonds Are Screaming “Recession.” That’s Great News For One Top Sector. ↗

March 29, 2022

The 10-2 year treasury yield spread is close to zero. Here's what you should do about this warning sign of a coming recession.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 02, 2022

Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...

Via Benzinga

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi ↗

March 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

March 02, 2022

Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the...

Via Talk Markets

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

3 Moonshot Stocks Insiders Are Buying. What Do They Know? ↗

February 25, 2022

Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature.

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.